DDS: 动态甘油三酯水平对高甘油三酯血症性胰腺炎患者复发风险的影响

2019-04-21 不详 MedSci原创

甘油三酯严重影响胰腺炎患者的疾病发展,因此,本项研究旨在探究动态甘油三酯水平对高甘油三酯血症性胰腺炎患者复发性胰腺炎风险的影响。

背景及目的
甘油三酯严重影响胰腺炎患者的疾病发展,因此,本项研究旨在探究动态甘油三酯水平对高甘油三酯血症性胰腺炎患者复发性胰腺炎风险的影响。

方法
研究人员对2006年至2013年间在当地医院就诊的急性胰腺炎住院期间血清甘油三酯水平≥500mg / dL的患者进行了纵向回顾性队列研究(随访至2015年)。williamhill asia 使用多变量稳健泊松回归来确定基线(首次门诊)甘油三酯测量对复发性胰腺炎风险的独立影响。门诊甘油三酯水平分为正常(0-200 mg / dL),中度升高(201-500 mg / dL)和高度升高(> 500 mg / dL)。williamhill asia 进一步评估了与门诊患者血清甘油三酯(<200 mg / dL)正常化可能性相关的因素。

结果
151名患者符合研究纳入标准,中位随访时间为3年。总体而言,45名(29.8%)患者至少经历过1次复发,其中25名(16.6%)经历过多次发作。在多变量分析中,持续中度升高(RR 5.47(95%CI: 1.80,16.65))以及高度升高(RR 8.45(95%CI:2.55,27.96))甘油三酯的患者发生疾病复发的风险增加对于那些达到正常化的患者,在出院后30天内进行甘油三酯测量的患者更有可能达到正常化(40% VS 26%,p= 0.03)。

结论
对于高甘油三酯血症性胰腺炎患者,随后甘油三酯水平的适度升高与复发风险增加有关。

原始出处:

本文系williamhill asia 医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1905526, encodeId=f276190552601, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42597, encryptionId=0eb34259ea1, topicName=复发风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca20190, createdName=wushaoling, createdTime=Fri Jul 19 13:26:00 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654724, encodeId=e47c1654e246c, content=<a href='/topic/show?id=edc610251468' target=_blank style='color:#2F92EE;'>#高甘油三酯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102514, encryptionId=edc610251468, topicName=高甘油三酯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5a424532179, createdName=flyingeagle85, createdTime=Mon Dec 23 19:26:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486774, encodeId=9b271486e74db, content=<a href='/topic/show?id=8ca1102515ec' target=_blank style='color:#2F92EE;'>#高甘油三酯血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102515, encryptionId=8ca1102515ec, topicName=高甘油三酯血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bf8208819, createdName=bioon4, createdTime=Tue Apr 23 05:26:00 CST 2019, time=2019-04-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1905526, encodeId=f276190552601, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42597, encryptionId=0eb34259ea1, topicName=复发风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca20190, createdName=wushaoling, createdTime=Fri Jul 19 13:26:00 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654724, encodeId=e47c1654e246c, content=<a href='/topic/show?id=edc610251468' target=_blank style='color:#2F92EE;'>#高甘油三酯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102514, encryptionId=edc610251468, topicName=高甘油三酯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5a424532179, createdName=flyingeagle85, createdTime=Mon Dec 23 19:26:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486774, encodeId=9b271486e74db, content=<a href='/topic/show?id=8ca1102515ec' target=_blank style='color:#2F92EE;'>#高甘油三酯血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102515, encryptionId=8ca1102515ec, topicName=高甘油三酯血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bf8208819, createdName=bioon4, createdTime=Tue Apr 23 05:26:00 CST 2019, time=2019-04-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1905526, encodeId=f276190552601, content=<a href='/topic/show?id=0eb34259ea1' target=_blank style='color:#2F92EE;'>#复发风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42597, encryptionId=0eb34259ea1, topicName=复发风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca20190, createdName=wushaoling, createdTime=Fri Jul 19 13:26:00 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1654724, encodeId=e47c1654e246c, content=<a href='/topic/show?id=edc610251468' target=_blank style='color:#2F92EE;'>#高甘油三酯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102514, encryptionId=edc610251468, topicName=高甘油三酯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5a424532179, createdName=flyingeagle85, createdTime=Mon Dec 23 19:26:00 CST 2019, time=2019-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486774, encodeId=9b271486e74db, content=<a href='/topic/show?id=8ca1102515ec' target=_blank style='color:#2F92EE;'>#高甘油三酯血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102515, encryptionId=8ca1102515ec, topicName=高甘油三酯血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91bf8208819, createdName=bioon4, createdTime=Tue Apr 23 05:26:00 CST 2019, time=2019-04-23, status=1, ipAttribution=)]